Mounjaro and HRT: What UK Women Need to Know

If you're going through the menopause and thinking about Mounjaro, there's a good chance you're already on HRT. And somewhere between booking your consultation and reading the patient leaflet, a quiet worry creeps in: will these two treatments get in each other's way?

It's a fair question, and one your GP is hearing more and more. The short answer is reassuring. You can use Mounjaro and HRT together. But the form your HRT takes really matters, and if you're on tablets, there are a few things worth sorting out before you start.

Can you take Mounjaro and HRT together?

Yes. There's no rule that says you must stop one to have the other, and for many women the two work well side by side. Menopause and excess weight often travel together, and treating both can make a real difference to how you feel.

The nuance is this. Mounjaro doesn't clash with the hormones in HRT in any dangerous, direct way. What it can do is change how well your body absorbs HRT when you take it as a tablet you swallow. That's a solvable problem, not a reason to avoid treatment. It just needs a short conversation with whoever prescribes your HRT before you begin.

If you take your HRT as a patch, gel, spray or through a Mirena coil, you can largely relax on this point. The interaction we're about to explain simply doesn't apply to you in the same way.

Why Mounjaro can interfere with oral HRT

Mounjaro works partly by slowing down how quickly your stomach empties. That's a feature, not a fault. Slower stomach emptying is a big reason food stays with you for longer and appetite settles down. But anything you swallow, including a hormone tablet, sits in that slower system too, and it can be absorbed less completely.

We can put rough numbers on this. When the manufacturer tested tirzepatide alongside a combined oral contraceptive, a single 5 mg dose reduced the peak level of the contraceptive hormones in the blood by roughly 55 to 66 per cent, with a smaller drop of 16 to 23 per cent in total exposure, and delayed the time to peak by a few hours. The effect was strongest with the first dose and after each dose increase, and faded once someone had been on a steady dose for a few weeks.

Oral HRT hasn't been studied in the same detail, so we're reasoning by extension here. But the mechanism is the same, and the British Menopause Society treats the risk as real enough to plan around.

The part that matters most is the progestogen. In combined HRT, oestrogen eases your symptoms while progestogen keeps the lining of your womb thin and healthy. If progestogen absorption dips, that protection can slip, which is why this is worth taking seriously rather than shrugging off.

Does the interaction settle over time?

This is the part that reassures a lot of women, and it's rarely explained well elsewhere. The absorption effect isn't constant. It's at its strongest when your body is newly exposed to a bigger dose, and it eases as you settle onto a steady one.

In the manufacturer's testing, the drop in hormone levels was most pronounced after that first 5 mg dose and after each step up. Once someone had taken the same dose for around four weeks, the effect on absorption had largely faded. Mounjaro is designed to be increased gradually over months, so in practice the vulnerable windows are the start of treatment and each dose increase, not the whole time you're on it.

That's why the advice keeps coming back to timing. Reviewing your HRT when you begin Mounjaro and taking oral HRT and Mounjaro together through each dose change is when it matters most. There's also a simpler culprit worth naming: if common side effects like nausea or diarrhoea have you vomiting within a few hours of swallowing a tablet, that dose may not be absorbed at all. Skin-based HRT sidesteps that problem entirely.

Which types of HRT are affected?

Not all HRT is equal here, and this is genuinely good news. The route your hormones take into your body decides whether Mounjaro has any say in the matter. Anything absorbed through the skin or released directly inside the womb skips the stomach entirely.

Here's how the common preparations stack up, following the British Menopause Society's 2025 guidance for clinicians:

There's a second reason patches and gels tend to win out for women who carry extra weight. Oral oestrogen slightly raises the risk of blood clots, while oestrogen through the skin is considered neutral for clot risk. Obesity already nudges clot risk upward, so transdermal HRT is frequently the preferred choice regardless of Mounjaro. If you're moving to a skin-based route to sidestep the absorption issue, you may be gaining a small safety bonus at the same time.

What this means for your womb, and why bleeding matters

Let's talk plainly about the thing underneath all of this. If you have a womb and you're taking oestrogen, you need enough progestogen to keep the womb lining thin. Without it, the lining can thicken over time, and thickening is what raises the risk of problems, including, rarely, endometrial cancer.

So if Mounjaro quietly lowers how much oral progestogen you absorb, the worry isn't the medication itself. It's that your womb might be less protected than the prescription on paper suggests. Usually the first sign that something has shifted is bleeding, which is why bleeding is the symptom to take seriously.

Unscheduled bleeding on HRT is common in general. It affects up to 40 per cent of users at some point, and most of the time it turns out to be nothing sinister. But common doesn't mean ignorable. New bleeding, spotting, heavier bleeding than usual, or the return of symptoms like hot flushes can all be a clue that your hormone levels have dropped.

Your options if you're on oral HRT

If you take HRT tablets and want to start Mounjaro, or you're already on Mounjaro and about to begin HRT, you have choices. None of them involves giving up on either treatment. Talk them through with your prescriber and pick what fits your life.

Switch to a patch, gel or spray. This is the cleanest fix. Skin-based HRT delivers steady hormone levels that don't depend on your stomach, so the whole absorption question disappears. For most women on Mounjaro, this is the route their clinician will suggest first.

Consider the Mirena coil for progestogen. The 52 mg Mirena releases progestogen directly into the womb, giving reliable protection for up to five years that Mounjaro can't touch. You'd pair it with oestrogen through a patch or gel. For a lot of women this combination is the most dependable set-up of all, and it doubles as contraception if you still need it.

Stay on oral progestogen, with a review. If you'd rather not change, one pragmatic approach is a temporary increase in your progestogen dose for about four weeks after starting Mounjaro, and again after each dose step-up, until you settle on a stable dose. The exact dose isn't fixed in the evidence, so this only happens under your prescriber's supervision, with you tracking any bleeding.

Ask about Wegovy. Wegovy (semaglutide) is a close cousin of Mounjaro, and small studies haven't shown the same drop in oral hormone absorption. If staying on oral HRT really matters to you, it's worth asking whether switching from Mounjaro to Wegovy might suit you better. That's a decision to make with a clinician, weighing up how each medication works for you.

Whichever path you choose, timing helps. The absorption effect is strongest at the start and after every dose increase, so those are the moments to have your HRT reviewed rather than waiting for a problem to appear.

Don't forget contraception in perimenopause

One thing that catches women out: HRT is not contraception. If you're perimenopausal, you can still get pregnant, and the same slowing of stomach emptying that affects oral HRT also affects the contraceptive pill.

Because of this, the MHRA advised in June 2025 that women using tirzepatide who rely on the pill should either switch to a non-oral method or add a barrier method, such as condoms, for four weeks after starting and for four weeks after each dose increase. Mounjaro also shouldn't be used in pregnancy, so reliable contraception is part of using it safely. A Mirena coil, again, neatly solves both the HRT and the contraception question at once.

Weight loss, menopause and your womb: the upside

It's easy to read all of this as a list of things to worry about. It isn't. The interaction is manageable, and there's a genuinely encouraging side to combining these treatments.

For a start, carrying less weight is good for your womb. Obesity raises the risk of endometrial problems, and sustained weight loss appears to bring that risk back down. So the same treatment that prompts a tweak to your HRT is also working in your favour on the very risk we've been discussing.

There's also a hint that HRT and weight loss medication may complement each other. In one 2024 study of postmenopausal women on semaglutide, those also using hormone therapy lost about 16 per cent of their starting weight over a year, compared with 12 per cent for those on the medication alone. It's a small study, and it looked at semaglutide rather than tirzepatide, so hold it loosely. But it fits what many women describe: getting menopause symptoms under control makes it easier to stick with the habits that support weight loss.

Mounjaro is licensed in the UK for managing obesity and overweight with a weight-related condition, so it isn't for everyone, and menopause alone isn't a reason to take it. It's worth understanding who qualifies for treatment before you get your hopes up either way. But if you meet the criteria and you're already on HRT, this combination is well-trodden ground. Plenty of women are doing exactly this, safely, with a bit of planning.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.